Higher incidence of diabetes in liver transplant recipients with hepatitis C

Hilla Knobler, Alex Stagnaro-Green, Sylvan Wallenstein, Myron Schwartz, Sheila H. Roman

Research output: Contribution to journalArticle

Abstract

We assessed the clinical and biochemical parameters associated with the development of posttransplantation diabetes (PTDM) in 52 liver transplant recipients followed up for 1 year. Diabetes was present before transplantation in 9.6% (5 of 52) of patients, and PTDM occurred in 23% (11 of 47) of the remaining liver transplant recipients. Of the 13 patients who had hepatitis C as the cause of their liver failure (HC-LD), 8 (62%) developed PTDM; of the 34 patients with other causes of liver failure, 3 (9%) developed PTDM (p <0.001). Posttransplantation diabetes was also associated with the development of early posttransplantation hyperglycemia, a higher number of liver rejection episodes, and lower serum albumin levels at 6 months. The association of PTDM with HC-LD remained significant in a logistic regression model after adjustment for potential confounding variables. We conclude that PTDM is common in liver transplant recipients. Associated clinical parameters predictive of PTDM include a diagnosis of HC-LD before transplantation, the development of early hyperglycemia after transplantation, multiple episodes of posttransplantation liver rejection and low serum albumin levels at 6 months. The fact that HC-LD remained an independent risk factor for the development of PTDM may suggest a direct or immune-mediated pancreatic effect of the virus.

Original languageEnglish (US)
Pages (from-to)30-33
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume26
Issue number1
DOIs
StatePublished - Jan 1998
Externally publishedYes

Fingerprint

Hepatitis C
Liver
Incidence
Transplantation
Liver Failure
Serum Albumin
Hyperglycemia
Logistic Models
Confounding Factors (Epidemiology)
Transplant Recipients
Viruses

Keywords

  • Diabetes mellitus
  • Hepatitis C
  • Liver transplantation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Higher incidence of diabetes in liver transplant recipients with hepatitis C. / Knobler, Hilla; Stagnaro-Green, Alex; Wallenstein, Sylvan; Schwartz, Myron; Roman, Sheila H.

In: Journal of Clinical Gastroenterology, Vol. 26, No. 1, 01.1998, p. 30-33.

Research output: Contribution to journalArticle

Knobler, Hilla ; Stagnaro-Green, Alex ; Wallenstein, Sylvan ; Schwartz, Myron ; Roman, Sheila H. / Higher incidence of diabetes in liver transplant recipients with hepatitis C. In: Journal of Clinical Gastroenterology. 1998 ; Vol. 26, No. 1. pp. 30-33.
@article{a33658841f1f4168856f9734e11f62fd,
title = "Higher incidence of diabetes in liver transplant recipients with hepatitis C",
abstract = "We assessed the clinical and biochemical parameters associated with the development of posttransplantation diabetes (PTDM) in 52 liver transplant recipients followed up for 1 year. Diabetes was present before transplantation in 9.6{\%} (5 of 52) of patients, and PTDM occurred in 23{\%} (11 of 47) of the remaining liver transplant recipients. Of the 13 patients who had hepatitis C as the cause of their liver failure (HC-LD), 8 (62{\%}) developed PTDM; of the 34 patients with other causes of liver failure, 3 (9{\%}) developed PTDM (p <0.001). Posttransplantation diabetes was also associated with the development of early posttransplantation hyperglycemia, a higher number of liver rejection episodes, and lower serum albumin levels at 6 months. The association of PTDM with HC-LD remained significant in a logistic regression model after adjustment for potential confounding variables. We conclude that PTDM is common in liver transplant recipients. Associated clinical parameters predictive of PTDM include a diagnosis of HC-LD before transplantation, the development of early hyperglycemia after transplantation, multiple episodes of posttransplantation liver rejection and low serum albumin levels at 6 months. The fact that HC-LD remained an independent risk factor for the development of PTDM may suggest a direct or immune-mediated pancreatic effect of the virus.",
keywords = "Diabetes mellitus, Hepatitis C, Liver transplantation",
author = "Hilla Knobler and Alex Stagnaro-Green and Sylvan Wallenstein and Myron Schwartz and Roman, {Sheila H.}",
year = "1998",
month = "1",
doi = "10.1097/00004836-199801000-00009",
language = "English (US)",
volume = "26",
pages = "30--33",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Higher incidence of diabetes in liver transplant recipients with hepatitis C

AU - Knobler, Hilla

AU - Stagnaro-Green, Alex

AU - Wallenstein, Sylvan

AU - Schwartz, Myron

AU - Roman, Sheila H.

PY - 1998/1

Y1 - 1998/1

N2 - We assessed the clinical and biochemical parameters associated with the development of posttransplantation diabetes (PTDM) in 52 liver transplant recipients followed up for 1 year. Diabetes was present before transplantation in 9.6% (5 of 52) of patients, and PTDM occurred in 23% (11 of 47) of the remaining liver transplant recipients. Of the 13 patients who had hepatitis C as the cause of their liver failure (HC-LD), 8 (62%) developed PTDM; of the 34 patients with other causes of liver failure, 3 (9%) developed PTDM (p <0.001). Posttransplantation diabetes was also associated with the development of early posttransplantation hyperglycemia, a higher number of liver rejection episodes, and lower serum albumin levels at 6 months. The association of PTDM with HC-LD remained significant in a logistic regression model after adjustment for potential confounding variables. We conclude that PTDM is common in liver transplant recipients. Associated clinical parameters predictive of PTDM include a diagnosis of HC-LD before transplantation, the development of early hyperglycemia after transplantation, multiple episodes of posttransplantation liver rejection and low serum albumin levels at 6 months. The fact that HC-LD remained an independent risk factor for the development of PTDM may suggest a direct or immune-mediated pancreatic effect of the virus.

AB - We assessed the clinical and biochemical parameters associated with the development of posttransplantation diabetes (PTDM) in 52 liver transplant recipients followed up for 1 year. Diabetes was present before transplantation in 9.6% (5 of 52) of patients, and PTDM occurred in 23% (11 of 47) of the remaining liver transplant recipients. Of the 13 patients who had hepatitis C as the cause of their liver failure (HC-LD), 8 (62%) developed PTDM; of the 34 patients with other causes of liver failure, 3 (9%) developed PTDM (p <0.001). Posttransplantation diabetes was also associated with the development of early posttransplantation hyperglycemia, a higher number of liver rejection episodes, and lower serum albumin levels at 6 months. The association of PTDM with HC-LD remained significant in a logistic regression model after adjustment for potential confounding variables. We conclude that PTDM is common in liver transplant recipients. Associated clinical parameters predictive of PTDM include a diagnosis of HC-LD before transplantation, the development of early hyperglycemia after transplantation, multiple episodes of posttransplantation liver rejection and low serum albumin levels at 6 months. The fact that HC-LD remained an independent risk factor for the development of PTDM may suggest a direct or immune-mediated pancreatic effect of the virus.

KW - Diabetes mellitus

KW - Hepatitis C

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=0031951743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031951743&partnerID=8YFLogxK

U2 - 10.1097/00004836-199801000-00009

DO - 10.1097/00004836-199801000-00009

M3 - Article

C2 - 9492860

AN - SCOPUS:0031951743

VL - 26

SP - 30

EP - 33

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 1

ER -